Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care, Biosensors and Rapid Diagnostics Europe 2023

Francesco Dal Dosso's Biography



Francesco Dal Dosso, Innovation Manager, KU Leuven

Dr. Francesco Dal Dosso obtained a MSc. in Biomedical Engineering (Polytechnic of Milan, IT – 2013) and a PhD in Bioscience Engineering (KU Leuven, BE – 2018). Currently, he works as Innovation Manager at the KU Leuven, the most innovative university in Europe (and 7th in the world). As Innovation Manager, FDD is responsible for the exploitation/commercialization of the research done in the IDiaLiST (Integrated Diagnostic and Life Science Research Tools) consortium. In this context, FDD scouts for new exploitation opportunities such as spin-off creation, industrial collaborations, patent applications and licensing. His main research interests involve novel concepts for point-of-care in vitro diagnostics and microsampling exploiting microfluidics technologies. He has been involved in writing and management of >10 (inter)national project funding proposals (KU Leuven, FWO, VLAIO, H2020, H Europe, Bill and Melinda Gates Foundation) as well as bilateral agreement with world-leading diagnostics and pharma companies. He is (co-)author of > 35 peer reviewed research papers and conference contributions (Biosensors, MicroTAS) and inventor of 5 patents.

Francesco Dal Dosso Image

(i)SIMPLE – Only One Finger Press Away From Enabling Decentralized Healthcare

Tuesday, 20 June 2023 at 18:00

Add to Calendar ▼2023-06-20 18:00:002023-06-20 19:00:00Europe/London(i)SIMPLE – Only One Finger Press Away From Enabling Decentralized HealthcarePoint-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

We present a novel self-powered microfluidic technology, named (i)SIMPLE, capable of unparalleled complex liquid manipulations in a user-friendly manner (single user activation step). (i)SIMPLE has been exploited as a [1] self-sampling and processing cartridge for remote collection of biofluids, [2] companion diagnostic chip for personalized therapeutic drug monitoring and [3] all-in-one device for POC (molecular) diagnosis of infectious diseases. The devices are low-cost and compatible with high throughput manufacturing, ready for industrialization.


Add to Calendar ▼2023-06-19 00:00:002023-06-20 00:00:00Europe/LondonPoint-of-Care, Biosensors and Rapid Diagnostics Europe 2023Point-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com